AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment

Recruitingn/aAges 18 Years - anyAllUnion Hospital, Tongji Medical College, Huazhong …
💬

In plain words

What the trial is, and whether it could suit you

This is a prospective observational cohort study (AI-Kidney-Prognosis), aiming to non-invasively predict the clinical outcomes in renal cell carcinoma patients after surgical treatment using radiomics-based AI models, thereby assisting clinical decision-making and personalized follow-up strategies.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: 1. Patients were treated for renal cell carcinoma in Wuhan Union Hospital from August 2025 to August 2026; 2. Aged \> 18 years old; 3. At least one abdominal CT scan before treatment; 4. Tissue biopsy pathological examination confirmed the diagnosis of renal cell carcinoma. Exclusion Criteria: 1. Poor image quality; 2. Incomplete clinical data or loss of follow-up; 3. Presence of another primary malignancy other than renal cell carcinoma; 4. Unclear pathological diagnosis.
💊

What it tests

  • Not listed
📍

Where

1 site
Union Hospital,Tongji Medical College,Huazhong University of Science and Technology
Wuhan, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy